This five-minute explainer on the CANTOS, REVEAL and COMPASS studies puts the findings in real-world context for cardiologists.
The lead investigator of the pivotal SENTINEL trial explains what the data suggest about when to use the newly FDA-approved Sentinel device for cerebral embolic protection during TAVR procedures.
In this video case study, video-assisted thoracoscopic surgery is employed for pneumonectomy in a 67-year-old with a lung tumor. The surgeon walks us through the essential operative steps.
This two-minute video shows how Cleveland Clinic is using virtual reality scenarios to teach cardiac surgery residents how to maintain ideal performance under the pressure of OR crises.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Give him 90 seconds, and Dr. Stephen Ellis will explain how iFR has improved the prospects for physiologic assessment over what FFR has offered — and why it matters.
A Cleveland Clinic interventional cardiologist puts the SURTAVI trial in context and speaks to what’s needed to help intermediate-risk patients make the best choice between two good AVR options.
Despite the equivocal results of the ABSORB trials to date, the key question remains what happens over the long term with these devices.
As the dust settles in the wake of the FOURIER trial results, how should we translate them into practice? Dr. Steven Nissen shares his thoughts on this, as well as PCSK9 inhibitor safety, in this two-minute video.
Up to 45 percent of patients with critical limb ischemia (CLI) are rehospitalized within 90 days. Dr. Mehdi Shishehbor shares insights on how to curb that rate from important publications on CLI over the past year.
Pericarditis develops into complicated disease in only a minority of patients, but their care has garnered relatively little interest. A new paper in JACC aims to change that, and its lead author gives a taste of its content in this video.